Habib Dable
InvestorAdvisor at RA Capital
Cambridge, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
Habib Dable is an Advisor at Raven, where he advises and supports new companies, portfolio companies, and executives. He previously spent five years as President and CEO of Acceleron Pharma, which was acquired by Merck in 2021, and earlier held leadership roles over roughly 22 years at Bayer AG, including President, U.S. Pharmaceuticals. He holds a BBA and MBA from the University of New Brunswick and completed executive programs at Stanford University and Korn/Ferry.
Invests in
Biotech
Experience
- RA Capital Management, L.P.Advisorcurrent2022 — presentBoston, Massachusetts, United States
- Atavistik BioBoard Membercurrent2026 — presentCambridge, Massachusetts, United States
- Tyra BiosciencesIndependent Board Directorcurrent2026 — presentCarlsbad, California, United States
- SpyGlass Pharma, Inc.Independent Board Directorcurrent2026 — presentIrvine, California, United States
- Relay TherapeuticsIndependent Board Directorcurrent2025 — presentCambridge, Massachusetts, United States
- PepGenIndependent Board Directorcurrent2022 — presentCambridge, Massachusetts, United States
- BIOLINK.orgBoard Membercurrent2022 — present
- Day One BiopharmaceuticalsIndependent Board Director2024 — 2026Brisbane, California, United States
- Blueprint MedicinesIndependent Board Director2022 — 2025Cambridge, Massachusetts, United States
- Aerovate Therapeutics, Inc.Board Chair2024 — 2025
- Aerovate Therapeutics, Inc.Independent Board Director2023 — 2025Cambridge, Massachusetts, United States
- Albireo Pharma, Inc.Independent Board Director2022 — 2023Cambridge, Massachusetts, United States
- Acceleron PharmaPresident & CEO2016 — 2021Cambridge, Massachusetts
- MILLENDO THERAPEUTICSIndependent Board Director2018 — 2021Ann Arbor, Michigan
- Biotechnology Innovation OrganizationMember Board Of Directors2016 — 2017
- BayerPresident, U.S. Pharmaceuticals2015 — 2016Whippany, New Jersey
- BayerEVP, Global Head Specialty Medicine2013 — 2015Whippany, New Jersey
- BayerVP Ophthalmology & Global Launch Team Head - EYLEA®2010 — 2012Whippany, New Jersey
- BayerGlobal Head TA Neurology / Ophthalmology2008 — 2009Whippany, New Jersey
- BayerVP & Regional Business Unit Head2005 — 2008Berkeley, California
Education
- University of New BrunswickMaster of Business Administration - MBA, 1994
- University of New BrunswickBachelor of Business Administration - BBA, 1991
- Stanford University Graduate School of BusinessStanford Executive Program, 2007
Skills & more
Languages Arabic · English · Japanese
From Habib's professional profile.
Colleagues at RA Capital
Frequently asked questions
- Where does Habib Dable work?
- Habib Dable is Advisor at RA Capital.
- What does Habib Dable invest in?
- Habib Dable invests in Biotech.
- What check size does Habib Dable write?
- Habib Dable typically writes checks of $100K – $5M.
Founder mafias
Stanford University Graduate School of Business mafia250
Also came through, then founded or led a company.
+ 243 more
University of New Brunswick mafia5
Also came through, then founded or led a company.
Blueprint Medicines mafia3
Also came through, then founded or led a company.
RA Capital mafia3
Also came through, then founded or led a company.
Same school
Also attended University of New Brunswick11
+ 5 more
Also attended Stanford University Graduate School of Business1,291
+ 1,285 more
Shared employers
Also worked at Tyra Biosciences1
Also worked at Relay Therapeutics10
+ 4 more
Also worked at Day One Biopharmaceuticals1
Also worked at Bayer69
+ 63 more











































